DOD Biotech Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
DOD Biotech has a total shareholder equity of THB874.9M and total debt of THB87.1M, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are THB1.2B and THB328.8M respectively.
Wichtige Informationen
10.0%
Verhältnis von Schulden zu Eigenkapital
฿87.08m
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | ฿75.71m |
| Eigenkapital | ฿874.92m |
| Gesamtverbindlichkeiten | ฿328.82m |
| Gesamtvermögen | ฿1.20b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: DOD's short term assets (THB471.9M) exceed its short term liabilities (THB242.1M).
Langfristige Verbindlichkeiten: DOD's short term assets (THB471.9M) exceed its long term liabilities (THB86.7M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: DOD's net debt to equity ratio (1.3%) is considered satisfactory.
Schulden abbauen: DOD's debt to equity ratio has reduced from 10.4% to 10% over the past 5 years.
Schuldendeckung: DOD's debt is well covered by operating cash flow (66.1%).
Zinsdeckung: Insufficient data to determine if DOD's interest payments on its debt are well covered by EBIT.